Supplemental Consolidating Data - Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 26, 2022	Mar. 27, 2022	Jun. 30, 2023	Jun. 26, 2022
Cash flows from operating activities:
Net income	$ 173,830	$ 301,829	$ 215,849	$ 222,502	$ 475,659	$ 438,351
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization					72,225	77,389
Amortization of deferred loan origination costs					44,393	47,101
Amortization of financing origination fees					6,508	7,637
Provision for long-term employee benefits					(33,656)	(9,844)
Employee benefit plan contributions and payments					(2,882)	(5,466)
Stock compensation expense					44,413	19,765
Net change in wholesale finance receivables related to sales					(267,942)	(201,326)
Provision for credit losses	57,278		29,133		109,642	57,955
Deferred income taxes					(4,251)	2,475
Other, net					(31,160)	11,102
Changes in current assets and liabilities:
Accounts receivable, net					(79,531)	(134,605)
Finance receivables – accrued interest and other					3,189	4,255
Inventories, net					94,636	(33,986)
Accounts payable and accrued liabilities					(16,047)	(4,239)
Other current assets					(4,676)	(32,378)
Total adjustments					(65,139)	(194,165)
Net cash provided by operating activities					410,520	244,186
Cash flows from investing activities:
Capital expenditures					(86,526)	(55,015)
Origination of finance receivables					(2,128,983)	(2,511,193)
Collections on finance receivables					1,869,463	2,071,952
Other investing activities					850	797
Net cash used by investing activities					(345,196)	(493,459)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					1,446,304	495,785
Repayments of medium-term notes					(1,056,680)	(950,000)
Proceeds from securitization debt					547,706	1,826,891
Repayments of securitization debt					(645,377)	(610,205)
Borrowings of asset-backed commercial paper					33,547	425,253
Repayments of asset-backed commercial paper					(129,961)	(133,159)
Net decrease in unsecured commercial paper					(75,229)	(50,672)
Net increase in deposits					122,288	55,255
Dividends paid					(48,193)	(47,146)
Repurchase of common stock					(169,645)	(325,828)
Excess tax benefits from share-based payments
Other financing activities					76	(1,237)
Net cash provided by financing activities					24,836	684,937
Effect of exchange rate changes on cash, cash equivalents and restricted cash					(490)	(14,413)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		1,579,177		2,025,219	1,579,177	2,025,219
Net (decrease) increase in cash, cash equivalents and restricted cash					89,670	421,251
Cash, cash equivalents and restricted cash, end of period	1,668,847		2,446,470		1,668,847	2,446,470
Non-Financial Services Entities
Cash flows from financing activities:
Proceeds from securitization debt					0
Financial Services Entities
Cash flows from financing activities:
Proceeds from securitization debt					547,706
Reportable Legal Entities | Non-Financial Services Entities
Cash flows from operating activities:
Net income	130,872		152,007		387,258	310,968
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization					67,720	73,098
Amortization of deferred loan origination costs					0	0
Amortization of financing origination fees					354	348
Provision for long-term employee benefits					(33,656)	(9,844)
Employee benefit plan contributions and payments					(2,882)	(5,466)
Stock compensation expense					42,174	18,341
Net change in wholesale finance receivables related to sales					0	0
Provision for credit losses	0		0		0	0
Deferred income taxes					233	4,312
Other, net					(25,290)	5,678
Changes in current assets and liabilities:
Accounts receivable, net					(147,730)	(347,250)
Finance receivables – accrued interest and other					0	0
Inventories, net					94,636	(33,986)
Accounts payable and accrued liabilities					(30,340)	(5,423)
Other current assets					(12,329)	(48,633)
Total adjustments					(47,110)	(348,825)
Net cash provided by operating activities					340,148	(37,857)
Cash flows from investing activities:
Capital expenditures					(85,401)	(53,694)
Origination of finance receivables					0	0
Collections on finance receivables					0	0
Other investing activities					(1,650)	797
Net cash used by investing activities					(87,051)	(52,897)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					0	0
Repayments of medium-term notes					0	0
Proceeds from securitization debt						0
Repayments of securitization debt					0	0
Borrowings of asset-backed commercial paper					0	0
Repayments of asset-backed commercial paper					0	0
Net decrease in unsecured commercial paper					0	0
Net increase in deposits					0	0
Dividends paid					(48,193)	(47,146)
Repurchase of common stock					(169,645)	(325,828)
Excess tax benefits from share-based payments
Other financing activities					76	(1,237)
Net cash provided by financing activities					(217,762)	(374,211)
Effect of exchange rate changes on cash, cash equivalents and restricted cash					(729)	(13,149)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		1,021,798		1,078,205	1,021,798	1,078,205
Net (decrease) increase in cash, cash equivalents and restricted cash					34,606	(478,114)
Cash, cash equivalents and restricted cash, end of period	1,056,404		600,091		1,056,404	600,091
Reportable Legal Entities | Financial Services Entities
Cash flows from operating activities:
Net income	43,043		63,999		88,320	127,387
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization					4,505	4,291
Amortization of deferred loan origination costs					44,393	47,101
Amortization of financing origination fees					6,154	7,289
Provision for long-term employee benefits					0	0
Employee benefit plan contributions and payments					0	0
Stock compensation expense					2,239	1,424
Net change in wholesale finance receivables related to sales					0	0
Provision for credit losses	57,278		29,133		109,642	57,955
Deferred income taxes					(4,413)	(1,431)
Other, net					(5,788)	5,420
Changes in current assets and liabilities:
Accounts receivable, net					0	0
Finance receivables – accrued interest and other					3,189	4,255
Inventories, net					0	0
Accounts payable and accrued liabilities					80,563	223,086
Other current assets					6,836	6,592
Total adjustments					247,320	355,982
Net cash provided by operating activities					335,640	483,369
Cash flows from investing activities:
Capital expenditures					(1,125)	(1,321)
Origination of finance receivables					(4,076,675)	(4,379,674)
Collections on finance receivables					3,551,887	3,739,107
Other investing activities					0	0
Net cash used by investing activities					(525,913)	(641,888)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					1,446,304	495,785
Repayments of medium-term notes					(1,056,680)	(950,000)
Proceeds from securitization debt						1,826,891
Repayments of securitization debt					(645,377)	(610,205)
Borrowings of asset-backed commercial paper					33,547	425,253
Repayments of asset-backed commercial paper					(129,961)	(133,159)
Net decrease in unsecured commercial paper					(75,229)	(50,672)
Net increase in deposits					122,288	55,255
Dividends paid					0	0
Repurchase of common stock					0	0
Excess tax benefits from share-based payments
Other financing activities					2,500	0
Net cash provided by financing activities					245,098	1,059,148
Effect of exchange rate changes on cash, cash equivalents and restricted cash					239	(1,264)
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		557,379		947,014	557,379	947,014
Net (decrease) increase in cash, cash equivalents and restricted cash					55,064	899,365
Cash, cash equivalents and restricted cash, end of period	612,443		1,846,379		612,443	1,846,379
Consolidating Adjustments
Cash flows from operating activities:
Net income	(85)		(157)		81	(4)
Adjustments to reconcile Net income to Net cash provided by operating activities:
Depreciation and amortization					0	0
Amortization of deferred loan origination costs					0	0
Amortization of financing origination fees					0	0
Provision for long-term employee benefits					0	0
Employee benefit plan contributions and payments					0	0
Stock compensation expense					0	0
Net change in wholesale finance receivables related to sales					(267,942)	(201,326)
Provision for credit losses	0		0		0	0
Deferred income taxes					(71)	(406)
Other, net					(82)	4
Changes in current assets and liabilities:
Accounts receivable, net					68,199	212,645
Finance receivables – accrued interest and other					0	0
Inventories, net					0	0
Accounts payable and accrued liabilities					(66,270)	(221,902)
Other current assets					817	9,663
Total adjustments					(265,349)	(201,322)
Net cash provided by operating activities					(265,268)	(201,326)
Cash flows from investing activities:
Capital expenditures					0	0
Origination of finance receivables					1,947,692	1,868,481
Collections on finance receivables					(1,682,424)	(1,667,155)
Other investing activities					2,500	0
Net cash used by investing activities					267,768	201,326
Cash flows from financing activities:
Proceeds from issuance of medium-term notes					0	0
Repayments of medium-term notes					0	0
Proceeds from securitization debt					0	0
Repayments of securitization debt					0	0
Borrowings of asset-backed commercial paper					0	0
Repayments of asset-backed commercial paper					0	0
Net decrease in unsecured commercial paper					0	0
Net increase in deposits					0	0
Dividends paid					0	0
Repurchase of common stock					0	0
Excess tax benefits from share-based payments
Other financing activities					(2,500)	0
Net cash provided by financing activities					(2,500)	0
Effect of exchange rate changes on cash, cash equivalents and restricted cash					0	0
Cash, cash equivalents and restricted cash:
Cash, cash equivalents and restricted cash, beginning of period		$ 0		$ 0	0	0
Net (decrease) increase in cash, cash equivalents and restricted cash					0	0
Cash, cash equivalents and restricted cash, end of period	$ 0		$ 0		$ 0	$ 0